ORBIMED ADVISORS LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1055951 New York, NY

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$53,298,500

-$2,802,750 QoQ

Shares Held

925,000

0.0% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#160

of 2,506 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $634,822,752 across 5 Drug Manufacturers - General names. BMY ranks #4 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	257,900	$309,333,022
2	AZN	Astrazeneca PLC	915,700	$173,635,034
3	MRK	Merck & Co., Inc.	663,400	$85,246,900
4	BMY	Bristol Myers Squibb Co This page	925,000	$53,298,500
5	BIIB	Biogen Inc.	61,600	$13,309,296

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,298,500	925,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$56,101,250	925,000	+19.4%	Shares	Sole	2026-05-15
2025-12-31	$41,803,500	775,000	-47.9%	Shares	Sole	2026-02-17
2023-06-30	$95,157,600	1,488,000	-36.4%	Shares	Sole	2023-08-14
2023-03-31	$162,185,400	2,340,000	-9.5%	Shares	Sole	2023-05-15
2022-12-31	$185,983,555	2,584,900	0.0%	Shares	Sole	2023-02-14
2022-09-30	$183,760,541	2,584,900	+2.6%	Shares	Sole	2022-11-14
2022-06-30	$193,939,900	2,518,700	-3.4%	Shares	Defined	2022-08-15
2022-03-31	$190,440,331	2,607,700	-39.9%	Shares	Defined	2022-05-16
2021-12-31	$270,586,530	4,339,800	-3.9%	Shares	Defined	2022-02-14
2021-09-30	$267,176,218	4,515,400	0.0%	Shares	Defined	2021-11-15
2021-06-30	$301,719,028	4,515,400	0.0%	Shares	Defined	2021-08-16
2021-03-31	$285,057,202	4,515,400	+27.2%	Shares	Defined	2021-05-17
2020-12-31	$220,150,673	3,549,100	0.0%	Shares	Defined	2021-02-16
2020-09-30	$213,975,239	3,549,100	+23.1%	Shares	Defined	2020-11-16
2020-06-30	$169,473,360	2,882,200	+16.5%	Shares	Defined	2020-08-14
2020-03-31	$137,945,352	2,474,800	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.